The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Demineralized Allograft Bone Substitute Market Research Report 2024
Synopsis
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Global Demineralized Allograft Bone Substitute market is projected to reach US$ 844.1 million in 2029, increasing from US$ 560 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Demineralized Allograft Bone Substitute market research.
The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Demineralized Allograft Bone Substitute market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Demineralized Allograft Bone Substitute report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Global Demineralized Allograft Bone Substitute market is projected to reach US$ 844.1 million in 2029, increasing from US$ 560 million in 2022, with the CAGR of 6.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Demineralized Allograft Bone Substitute market research.
The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Demineralized Allograft Bone Substitute market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Segment by Type
Gel
Putty
Putty with Chips
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Demineralized Allograft Bone Substitute report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Demineralized Allograft Bone Substitute Market Overview
1.1 Product Overview and Scope of Demineralized Allograft Bone Substitute
1.2 Demineralized Allograft Bone Substitute Segment by Type
1.2.1 Global Demineralized Allograft Bone Substitute Market Value Comparison by Type (2023-2029)
1.2.2 Gel
1.2.3 Putty
1.2.4 Putty with Chips
1.2.5 Others
1.3 Demineralized Allograft Bone Substitute Segment by Application
1.3.1 Global Demineralized Allograft Bone Substitute Market Value by Application: (2023-2029)
1.3.2 Dental Surgery
1.3.3 Spine Surgery
1.3.4 Trauma Surgery
1.4 Global Demineralized Allograft Bone Substitute Market Size Estimates and Forecasts
1.4.1 Global Demineralized Allograft Bone Substitute Revenue 2018-2029
1.4.2 Global Demineralized Allograft Bone Substitute Sales 2018-2029
1.4.3 Global Demineralized Allograft Bone Substitute Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Demineralized Allograft Bone Substitute Market Competition by Manufacturers
2.1 Global Demineralized Allograft Bone Substitute Sales Market Share by Manufacturers (2018-2023)
2.2 Global Demineralized Allograft Bone Substitute Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Demineralized Allograft Bone Substitute Average Price by Manufacturers (2018-2023)
2.4 Global Demineralized Allograft Bone Substitute Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Demineralized Allograft Bone Substitute, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Demineralized Allograft Bone Substitute, Product Type & Application
2.7 Demineralized Allograft Bone Substitute Market Competitive Situation and Trends
2.7.1 Demineralized Allograft Bone Substitute Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Demineralized Allograft Bone Substitute Players Market Share by Revenue
2.7.3 Global Demineralized Allograft Bone Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Demineralized Allograft Bone Substitute Retrospective Market Scenario by Region
3.1 Global Demineralized Allograft Bone Substitute Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Demineralized Allograft Bone Substitute Global Demineralized Allograft Bone Substitute Sales by Region: 2018-2029
3.2.1 Global Demineralized Allograft Bone Substitute Sales by Region: 2018-2023
3.2.2 Global Demineralized Allograft Bone Substitute Sales by Region: 2024-2029
3.3 Global Demineralized Allograft Bone Substitute Global Demineralized Allograft Bone Substitute Revenue by Region: 2018-2029
3.3.1 Global Demineralized Allograft Bone Substitute Revenue by Region: 2018-2023
3.3.2 Global Demineralized Allograft Bone Substitute Revenue by Region: 2024-2029
3.4 North America Demineralized Allograft Bone Substitute Market Facts & Figures by Country
3.4.1 North America Demineralized Allograft Bone Substitute Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Demineralized Allograft Bone Substitute Sales by Country (2018-2029)
3.4.3 North America Demineralized Allograft Bone Substitute Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Demineralized Allograft Bone Substitute Market Facts & Figures by Country
3.5.1 Europe Demineralized Allograft Bone Substitute Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Demineralized Allograft Bone Substitute Sales by Country (2018-2029)
3.5.3 Europe Demineralized Allograft Bone Substitute Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Demineralized Allograft Bone Substitute Market Facts & Figures by Country
3.6.1 Asia Pacific Demineralized Allograft Bone Substitute Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Demineralized Allograft Bone Substitute Sales by Country (2018-2029)
3.6.3 Asia Pacific Demineralized Allograft Bone Substitute Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Demineralized Allograft Bone Substitute Market Facts & Figures by Country
3.7.1 Latin America Demineralized Allograft Bone Substitute Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Demineralized Allograft Bone Substitute Sales by Country (2018-2029)
3.7.3 Latin America Demineralized Allograft Bone Substitute Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Demineralized Allograft Bone Substitute Market Facts & Figures by Country
3.8.1 Middle East and Africa Demineralized Allograft Bone Substitute Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Demineralized Allograft Bone Substitute Sales by Country (2018-2029)
3.8.3 Middle East and Africa Demineralized Allograft Bone Substitute Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Demineralized Allograft Bone Substitute Sales by Type (2018-2029)
4.1.1 Global Demineralized Allograft Bone Substitute Sales by Type (2018-2023)
4.1.2 Global Demineralized Allograft Bone Substitute Sales by Type (2024-2029)
4.1.3 Global Demineralized Allograft Bone Substitute Sales Market Share by Type (2018-2029)
4.2 Global Demineralized Allograft Bone Substitute Revenue by Type (2018-2029)
4.2.1 Global Demineralized Allograft Bone Substitute Revenue by Type (2018-2023)
4.2.2 Global Demineralized Allograft Bone Substitute Revenue by Type (2024-2029)
4.2.3 Global Demineralized Allograft Bone Substitute Revenue Market Share by Type (2018-2029)
4.3 Global Demineralized Allograft Bone Substitute Price by Type (2018-2029)
5 Segment by Application
5.1 Global Demineralized Allograft Bone Substitute Sales by Application (2018-2029)
5.1.1 Global Demineralized Allograft Bone Substitute Sales by Application (2018-2023)
5.1.2 Global Demineralized Allograft Bone Substitute Sales by Application (2024-2029)
5.1.3 Global Demineralized Allograft Bone Substitute Sales Market Share by Application (2018-2029)
5.2 Global Demineralized Allograft Bone Substitute Revenue by Application (2018-2029)
5.2.1 Global Demineralized Allograft Bone Substitute Revenue by Application (2018-2023)
5.2.2 Global Demineralized Allograft Bone Substitute Revenue by Application (2024-2029)
5.2.3 Global Demineralized Allograft Bone Substitute Revenue Market Share by Application (2018-2029)
5.3 Global Demineralized Allograft Bone Substitute Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Demineralized Allograft Bone Substitute Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 J &J (DePuy Synthes)
6.2.1 J &J (DePuy Synthes) Corporation Information
6.2.2 J &J (DePuy Synthes) Description and Business Overview
6.2.3 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.2.4 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Product Portfolio
6.2.5 J &J (DePuy Synthes) Recent Developments/Updates
6.3 SeaSpine
6.3.1 SeaSpine Corporation Information
6.3.2 SeaSpine Description and Business Overview
6.3.3 SeaSpine Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SeaSpine Demineralized Allograft Bone Substitute Product Portfolio
6.3.5 SeaSpine Recent Developments/Updates
6.4 Xtant Medical
6.4.1 Xtant Medical Corporation Information
6.4.2 Xtant Medical Description and Business Overview
6.4.3 Xtant Medical Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xtant Medical Demineralized Allograft Bone Substitute Product Portfolio
6.4.5 Xtant Medical Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zimmer Biomet Demineralized Allograft Bone Substitute Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Stryker Demineralized Allograft Bone Substitute Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Straumann
6.6.1 Straumann Corporation Information
6.6.2 Straumann Description and Business Overview
6.6.3 Straumann Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Straumann Demineralized Allograft Bone Substitute Product Portfolio
6.7.5 Straumann Recent Developments/Updates
6.8 Wright Medical Group
6.8.1 Wright Medical Group Corporation Information
6.8.2 Wright Medical Group Description and Business Overview
6.8.3 Wright Medical Group Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wright Medical Group Demineralized Allograft Bone Substitute Product Portfolio
6.8.5 Wright Medical Group Recent Developments/Updates
6.9 Hans Biomed
6.9.1 Hans Biomed Corporation Information
6.9.2 Hans Biomed Description and Business Overview
6.9.3 Hans Biomed Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hans Biomed Demineralized Allograft Bone Substitute Product Portfolio
6.9.5 Hans Biomed Recent Developments/Updates
6.10 Arthrex
6.10.1 Arthrex Corporation Information
6.10.2 Arthrex Description and Business Overview
6.10.3 Arthrex Demineralized Allograft Bone Substitute Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Arthrex Demineralized Allograft Bone Substitute Product Portfolio
6.10.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Demineralized Allograft Bone Substitute Industry Chain Analysis
7.2 Demineralized Allograft Bone Substitute Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Demineralized Allograft Bone Substitute Production Mode & Process
7.4 Demineralized Allograft Bone Substitute Sales and Marketing
7.4.1 Demineralized Allograft Bone Substitute Sales Channels
7.4.2 Demineralized Allograft Bone Substitute Distributors
7.5 Demineralized Allograft Bone Substitute Customers
8 Demineralized Allograft Bone Substitute Market Dynamics
8.1 Demineralized Allograft Bone Substitute Industry Trends
8.2 Demineralized Allograft Bone Substitute Market Drivers
8.3 Demineralized Allograft Bone Substitute Market Challenges
8.4 Demineralized Allograft Bone Substitute Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
